Abstract

The pandemic of the novel coronavirus (SARS-Cov-2) that began at the end of 2019 continues to have a significant impact on our lives, and the importance of viral infectious diseases and infection control by vaccines has been reaffirmed. This issue of the Journal of Dermatology is dedicated to providing an update on the latest advances in cutaneous viral infections infectious diseases and cutaneous manifestations of COVID-19 and COVID-19 vaccines. This issue consists of four reviews. First, Dr. Otsuka discusses COVID-19 and COVID-19 vaccine-induced skin manifestations. COVID-19 and COVID-19 vaccination are known to cause various organ damage and sometimes excessive immune induction, which are also associated with various skin disorders. Next, Dr. Shimizu reviews cutaneous human papilloma virus (HPV) infection. Verrucae are common skin diseases, but they are also known to be associated with rare conditions like Epidermodysplasia verruciformis and skin cancer. Third, Dr. Imafuku will discuss the update of herpes simplex virus (HSV) infection. Recurrent herpes simplex is a disease that decreases the quality of life of patients, and accurate diagnosis and treatment of recurrence conditions are important to overcome it. Finally, Dr. Asada will present an overview of herpes zoster. Herpes zoster has undergone changes in epidemiology, and new methods of diagnosis and treatment have emerged in the past few years. Vaccine prophylaxis is another important topic. I hope that these review articles will provide useful information to dermatological clinicians and researchers, and that clinical and research progress in the field of intractable cutaneous viral infections will be made in the future.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.